Shenzhen - Delayed Quote • CNY
Nanjing Hicin Pharmaceutical Co., Ltd. (300584.SZ)
At close: April 26 at 3:04 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
505,192.96
517,832.19
526,465.34
578,315.04
706,295.71
Cost of Revenue
94,467.19
96,594.64
130,017.38
109,010.48
171,561.22
Gross Profit
410,725.77
421,237.55
396,447.96
469,304.56
534,734.49
Operating Expense
353,001.36
367,476.68
351,712.18
435,201.67
462,966.92
Operating Income
57,724.41
53,760.87
44,735.78
34,102.89
71,767.57
Net Non Operating Interest Income Expense
-7,702.62
-7,374.64
-6,321.64
-6,768.76
-6,554.43
Pretax Income
40,368.91
37,689.28
28,775.99
330,446.93
61,346.36
Tax Provision
2,909.35
1,373.73
-3,348.29
45,614.89
6,819.72
Net Income Common Stockholders
37,459.55
36,315.55
32,448.87
285,878.18
55,230.05
Basic EPS
0.31
0.30
0.27
2.38
0.46
Diluted EPS
0.31
0.30
0.27
2.38
0.46
Basic Average Shares
120,021.19
120,011.75
120,003.21
120,000.92
119,987.08
Diluted Average Shares
120,021.19
120,011.75
120,003.21
120,000.92
119,987.08
Total Operating Income as Reported
41,013.63
39,292.55
30,101.17
331,299.70
62,506.36
Total Expenses
447,468.54
464,071.33
481,729.56
544,212.15
634,528.14
Net Income from Continuing & Discontinued Operation
37,459.55
36,315.55
32,448.87
285,878.18
55,230.05
Normalized Income
45,811.24
43,143.23
38,690.73
287,608.39
57,446.86
Interest Income
1,121.89
960.84
1,015.43
779.82
507.23
Interest Expense
8,434.08
8,272.64
7,252.72
7,498.28
7,007.92
Net Interest Income
-7,702.62
-7,374.64
-6,321.64
-6,768.76
-6,554.43
EBIT
48,802.99
45,961.93
36,028.71
337,945.22
68,354.28
EBITDA
48,802.99
99,521.80
84,173.23
375,005.74
99,904.70
Reconciled Cost of Revenue
94,467.19
96,594.64
130,017.38
109,010.48
171,561.22
Reconciled Depreciation
--
53,559.88
48,144.52
37,060.52
31,550.42
Net Income from Continuing Operation Net Minority Interest
37,459.55
36,315.55
32,448.87
285,878.18
55,230.05
Total Unusual Items Excluding Goodwill
-9,000.33
-7,085.95
-8,322.48
-2,007.29
-2,494.07
Total Unusual Items
-9,000.33
-7,085.95
-8,322.48
-2,007.29
-2,494.07
Normalized EBITDA
57,803.32
106,607.75
92,495.71
377,013.03
102,398.77
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-648.65
-258.27
-2,080.62
-277.09
-277.26
12/31/2020 - 1/12/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade